Pacific Growth Securities Initiates Coverage on Auxilium Pharmaceuticals (AUXL) with a Buy
More News related to AUXL
- Auxilium Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
- Auxilium Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference
- BofA Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
- Collins Stewart Starts Auxilium Pharmaceuticals (AUXL) at Buy
- Agile Therapeutics Appoints Industry Expert, Al Altomari, as Chairman of Its Board of Directors
Pacific Growth Securities initiates coverage on Auxilium Pharmaceuticals (Nasdaq: AUXL) with a Buy.
Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that focuses on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.
Related Categories
New CoverageStocks Mentioned
+0.13Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
